These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3274884)

  • 1. A probable mechanism for allograft rejection in HLA-identical combinations.
    Brasile L; Clarke J; Cerilli J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):894-5. PubMed ID: 3274884
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA antigens in kidney allograft rejection.
    Sujirachato K; Chiewsilp P; Jirasiritham S; Mongkolsuk T; Sumethkul V
    Transplant Proc; 1996 Jun; 28(3):1272. PubMed ID: 8658656
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal transplantation in HLA-identical sibling pairs.
    Dohi K; Fukuda Y; Asahara T; Tabe Y; Yahata H; Takenaka M; Ono E; Marubayashi S; Omotehara T; Eto T
    Hiroshima J Med Sci; 1984 Mar; 33(1):1-9. PubMed ID: 6384141
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One HLA haplo-identical transfusion in first renal allograft recipients: effect on alloimmunisation, acute rejection episodes, and graft survival.
    Bayle F; Masson D; Zaoui P; Janbon B; Bensa JC; Vialtel P
    Transplant Proc; 1995 Aug; 27(4):2457-8. PubMed ID: 7652881
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine.
    Zemel SM; Shen SY; Weir MR; Dagher FJ; Bentley FR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-HLA antibodies after rejection of HLA identical kidney transplants.
    Zafar MN; Terasaki PI; Naqvi SA; Rizvi SA
    Clin Transpl; 2006; ():421-6. PubMed ID: 18365399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney transplantation: generic HLA DR compatibility reduces acute rejection episodes.
    Reviron D; Mercier P; Jaber K; Dussol B; Brunet P; Berland Y
    Transplant Proc; 1996 Oct; 28(5):2812-3. PubMed ID: 8908073
    [No Abstract]   [Full Text] [Related]  

  • 9. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
    Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
    Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal allograft tissue: its new role in patient management.
    Chan GS; Kwok J; Lam MF; Chan TM; Chan KW
    Histopathology; 2012 Jun; 60(7):1160-2. PubMed ID: 22439775
    [No Abstract]   [Full Text] [Related]  

  • 11. Kidneys from female donors are at increased risk for chronic allograft rejection.
    Odland MD; Kasiske BL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):912. PubMed ID: 8442266
    [No Abstract]   [Full Text] [Related]  

  • 12. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced incidence of chronic rejection in cyclosporine-treated solid organ recipients with donor antigen-specific hyporeactivity.
    Reinsmoen NL; Hertz MI; Kubo SH; Bolman RM; Matas AJ
    Transplant Proc; 1994 Oct; 26(5):2558-9. PubMed ID: 7940790
    [No Abstract]   [Full Text] [Related]  

  • 14. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
    Lachmann N; Terasaki PI; Schönemann C
    Clin Transpl; 2006; ():171-99. PubMed ID: 18365377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transplantation immunology (author's transl)].
    Vujaklija-Stipanović K
    Lijec Vjesn; 1981; 103(2-3):115-8. PubMed ID: 7031392
    [No Abstract]   [Full Text] [Related]  

  • 16. Rejection of HLA identical related kidney transplants.
    Salaman JR; Godfrey AM; Russell RB; Brown P; Festenstein H
    Tissue Antigens; 1976 Oct; 8(4):233-8. PubMed ID: 790646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of HLA typing in clinical kidney transplants: 30 years later.
    Matas AJ; Najarian JS
    Clin Transpl; 1993; ():428-30. PubMed ID: 7918175
    [No Abstract]   [Full Text] [Related]  

  • 19. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization to HLA antigens occurs in 95% of primary renal transplant rejections.
    Harmer AW; Koffman CG; Heads AJ; Vaughan RW
    Transplant Proc; 1995 Feb; 27(1):666-7. PubMed ID: 7879137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.